Promethera Biosciences
Promethera Biosciences is a biotechnology company developing regenerative medicine treatments for liver diseases.
5
Funding Rounds
$103.1m
Money raised
Overview
Promethera Biosciences is a biotechnology company developing regenerative medicine treatments for liver diseases.
-
Websites:
- Business model: B2B
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company Promethera Biosciences has raised a total of $103.08m in funding over 5 rounds.
Key Insights:
- Promethera Biosciences Series D round, December 2019: $8.4m
- Promethera Biosciences Series D round, May 2019: $44.4m
- Promothera , April 2018: $11.5m
- Promethera Biosciences Series B round: $31.48m
- Promethera Biosciences Series A round: $7.3m
Promethera Biosciences Series D round, December 2019
$8.4m
Promethera Biosciences Series D round, May 2019
$44.4m
Promothera , April 2018
$11.5m
Promethera Biosciences Series B round
$31.48m
Promethera Biosciences Series A round
$7.3m
Industries
Promethera Biosciences is active in the following industries: